Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/9026
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLan, Shao-Huan-
dc.contributor.authorLai, Chih-Cheng-
dc.contributor.authorChang, Shen-Peng-
dc.contributor.authordkk.-
dc.date.accessioned2024-12-14T05:09:56Z-
dc.date.available2024-12-14T05:09:56Z-
dc.date.issued2024-02-
dc.identifier.issn1684-1182-
dc.identifier.urihttp://localhost:8080/xmlui/handle/123456789/9026-
dc.language.isoen_USen_US
dc.publisherJournal of Microbiology, Immunology and Infectionen_US
dc.relation.ispartofseries;207-208-
dc.titleCorrigendum to <‘Efficacy and safety of anti-interleukin-5 therapy in patients with chronic obstructive pulmonary disease: A meta-analysis of randomized, controlled trials’>[J Microbiol Immunol Infect 55 (1) (2022) 26-35]en_US
dc.typeArticleen_US
Appears in Collections:Vol. 57 No. 1 (2024)

Files in This Item:
File Description SizeFormat 
207-208.pdf492.26 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.